Skip to main content
SpringerLink
Log in

Magnetic Resonance Imaging of the Myocardium, Coronary Arteries, and Anomalous Origin of Coronary Arteries

  • Chapter
  • First Online:
Book cover Coronary Artery Disease

Part of the book series: Cardiovascular Medicine ((CVM))

Abstract

Over the past decade, cardiovascular magnetic resonance imaging (CMRI) has emerged as an important, non-invasive imaging modality. In certain aspects, CMRI has become the gold standard in the assessment of ischemic and nonischemic cardiomyopathy. It has relatively high spatial and temporal resolution, and it is also reproducible and does not involve ionizing radiation. Therefore, it is an ideal modality for long-term imaging follow-up. Cardiovascular magnetic resonance imaging can assess ventricular function, myocardial ischemia, and viability in a single setting. There is also a growing interest in tissue T1 and T2 imaging, which can be used to characterize tissues with various disease pathologies.

Although coronary multi-detector computed tomographic angiography is now widely used to assess the coronary arteries, magnetic resonance imaging coronary angiography still has an important role in the evaluation of suspected anomalous coronary artery origin, especially in the younger population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J. 2004;25(21):1940–65.

    PubMed  Google Scholar 

  2. Hendel RC, Patel MR, Kramer CM, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol. 2006;48(7):1475–97.

    PubMed  Google Scholar 

  3. American College of Cardiology Foundation Task Force on Expert Consensus Documents, Hundley WG, Bluemke DA, Finn JP, et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol. 2010;55(23):2614–62.

    Google Scholar 

  4. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004;23 Suppl 1:S208–19.

    PubMed  Google Scholar 

  5. Russo V, Renzulli M, Buttazzi K, Fattori R. Acquired diseases of the thoracic aorta: role of MRI and MRA. Eur Radiol. 2006;16(4):852–65.

    PubMed  Google Scholar 

  6. Hansen T, Wikstrom J, Eriksson MO, et al. Whole-body magnetic resonance angiography of patients using a standard clinical scanner. Eur Radiol. 2006;16(1):147–53.

    PubMed  Google Scholar 

  7. Hu P, Chan J, Ngo LH, et al. Contrast-enhanced whole-heart coronary MRI with bolus infusion of gadobenate dimeglumine at 1.5 T. Magn Reson Med. 2011;65(2):392–8.

    PubMed  Google Scholar 

  8. Jerosch-Herold M, Seethamraju RT, Swingen CM, Wilke NM, Stillman AE. Analysis of myocardial perfusion MRI. J Magn Reson Imaging. 2004;19(6):758–70.

    PubMed  Google Scholar 

  9. Detre JA, Alsop DC, Vives LR, et al. Noninvasive MRI evaluation of cerebral blood flow in cerebrovascular disease. Neurology. 1998;50(3):633–41.

    CAS  PubMed  Google Scholar 

  10. Charles-Edwards EM, deSouza NM. Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging. 2006;6:135–43.

    PubMed Central  PubMed  Google Scholar 

  11. Kim HW, Lee D, Pohost GM. (31)P cardiovascular magnetic resonance spectroscopy: a unique approach to the assessment of the myocardium. Future Cardiol. 2009;5(6):523–7.

    CAS  PubMed  Google Scholar 

  12. Razavi R, Hill DL, Keevil SF, et al. Cardiac catheterisation guided by MRI in children and adults with congenital heart disease. Lancet. 2003;362(9399):1877–82.

    PubMed  Google Scholar 

  13. Zhang L, Chen WZ, Liu YJ, et al. Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus. Eur J Radiol. 2010;73(2):396–403.

    PubMed  Google Scholar 

  14. Meaney TF. Magnetic resonance without nuclear. Radiology. 1984;150(1):277.

    CAS  PubMed  Google Scholar 

  15. Pooley RA. AAPM/RSNA physics tutorial for residents: fundamental physics of MR imaging. Radiographics. 2005;25(4):1087–99.

    PubMed  Google Scholar 

  16. Jacobs MA, Ibrahim TS, Ouwerkerk R. AAPM/RSNA physics tutorials for residents: MR imaging: brief overview and emerging applications. Radiographics. 2007;27(4):1213–29.

    PubMed  Google Scholar 

  17. Morelli JN, Runge VM, Ai F, et al. An image-based approach to understanding the physics of MR artifacts. Radiographics. 2011;31(3):849–66.

    PubMed  Google Scholar 

  18. Plewes DB, Kucharczyk W. Physics of MRI: a primer. J Magn Reson Imaging. 2012;35(5):1038–54.

    PubMed  Google Scholar 

  19. Ridgway JP. Cardiovascular magnetic resonance physics for clinicians: part I. J Cardiovasc Magn Reson. 2010;12:71.

    PubMed Central  PubMed  Google Scholar 

  20. Zhang H, Maki JH, Prince MR. 3D contrast-enhanced MR angiography. J Magn Reson Imaging. 2007;25(1):13–25.

    CAS  PubMed  Google Scholar 

  21. Miyazaki M, Akahane M. Non-contrast enhanced MR angiography: established techniques. J Magn Reson Imaging. 2012;35(1):1–19.

    PubMed  Google Scholar 

  22. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996;93(5):841–2.

    CAS  PubMed  Google Scholar 

  23. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29(2):270–6.

    PubMed  Google Scholar 

  24. World Health Organization. Http://www.Who.Int/mediacentre/factsheets/fs317/en/index.Html.

  25. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions. Circulation. 1999;99(17):2345–57.

    CAS  PubMed  Google Scholar 

  26. Douglas PS, Khandheria B, Stainback RF, et al. ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine. J Am Coll Cardiol. 2008;51(11):1127–47.

    PubMed  Google Scholar 

  27. Hendel RC, Berman DS, Di Carli MF, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. J Am Coll Cardiol. 2009;53(23):2201–29.

    PubMed  Google Scholar 

  28. Cheong BY, Muthupillai R, Wilson JM, et al. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation. 2009;120(21):2069–76.

    PubMed  Google Scholar 

  29. Jahnke C, Nagel E, Gebker R, et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation. 2007;115(13):1769–76.

    PubMed  Google Scholar 

  30. Ingkanisorn WP, Kwong RY, Bohme NS, et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol. 2006;47(7):1427–32.

    PubMed  Google Scholar 

  31. Manning WJ, Atkinson DJ, Grossman W, Paulin S, Edelman RR. First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease. J Am Coll Cardiol. 1991;18(4):959–65.

    CAS  PubMed  Google Scholar 

  32. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation. 2003;108(11):1404–18.

    PubMed  Google Scholar 

  33. Lee DC, Simonetti OP, Harris KR, et al. Magnetic resonance versus radionuclide pharmacological stress perfusion imaging for flow-limiting stenoses of varying severity. Circulation. 2004;110(1):58–65.

    PubMed  Google Scholar 

  34. Klem I, Heitner JF, Shah DJ, et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol. 2006;47(8):1630–8.

    PubMed  Google Scholar 

  35. Nesto RW, Kowalchuk GJ. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol. 1987;59(7):23C–30.

    CAS  PubMed  Google Scholar 

  36. Al Jaroudi W, Iskandrian AE. Regadenoson: a new myocardial stress agent. J Am Coll Cardiol. 2009;54(13):1123–30.

    CAS  PubMed  Google Scholar 

  37. Cheong BY, Muthupillai R. Nephrogenic systemic fibrosis: a concise review for cardiologists. Tex Heart Inst J. 2010;37(5):508–15.

    PubMed Central  PubMed  Google Scholar 

  38. Wilke NM, Jerosch-Herold M, Zenovich A, Stillman AE. Magnetic resonance first-pass myocardial perfusion imaging: clinical validation and future applications. J Magn Reson Imaging. 1999;10(5):676–85.

    CAS  PubMed  Google Scholar 

  39. Wolff SD, Schwitter J, Coulden R, et al. Myocardial first-pass perfusion magnetic resonance imaging: a multicenter dose-ranging study. Circulation. 2004;110(6):732–7.

    CAS  PubMed  Google Scholar 

  40. Schwitter J, Wacker CM, van Rossum AC, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J. 2008;29(4):480–9.

    PubMed  Google Scholar 

  41. Schwitter J, Wacker CM, Wilke N, et al. MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart J. 2013;34(10):775–81.

    PubMed  Google Scholar 

  42. Donahue KM, Weisskoff RM, Burstein D. Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imaging. 1997;7(1):102–10.

    CAS  PubMed  Google Scholar 

  43. Jerosch-Herold M, Muehling O. Stress perfusion magnetic resonance imaging of the heart. Top Magn Reson Imaging. 2008;19(1):33–42.

    PubMed  Google Scholar 

  44. Schwitter J. Myocardial perfusion imaging by cardiac magnetic resonance. J Nucl Cardiol. 2006;13(6):841–54.

    PubMed  Google Scholar 

  45. Wang Y, Moin K, Akinboboye O, Reichek N. Myocardial first pass perfusion: steady-state free precession versus spoiled gradient echo and segmented echo planar imaging. Magn Reson Med. 2005;54(5):1123–9.

    PubMed  Google Scholar 

  46. Cheng AS, Pegg TJ, Karamitsos TD, et al. Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla. J Am Coll Cardiol. 2007;49(25):2440–9.

    PubMed  Google Scholar 

  47. Manka R, Vitanis V, Boesiger P, et al. Clinical feasibility of accelerated, high spatial resolution myocardial perfusion imaging. JACC Cardiovasc Imaging. 2010;3(7):710–7.

    PubMed  Google Scholar 

  48. Motwani M, Maredia N, Fairbairn TA, et al. High-resolution versus standard-resolution cardiovascular MR myocardial perfusion imaging for the detection of coronary artery disease. Circ Cardiovasc Imaging. 2012;5(3):306–13.

    PubMed  Google Scholar 

  49. Hamon M, Fau G, Nee G, Ehtisham J, Morello R. Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J Cardiovasc Magn Reson. 2010;12(1):29.

    PubMed Central  PubMed  Google Scholar 

  50. Greenwood JP, Maredia N, Younger JF, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet. 2012;379(9814):453–60.

    PubMed Central  PubMed  Google Scholar 

  51. Nagel E, Klein C, Paetsch I, et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation. 2003;108(4):432–7.

    PubMed  Google Scholar 

  52. Klocke FJ, Simonetti OP, Judd RM, et al. Limits of detection of regional differences in vasodilated flow in viable myocardium by first-pass magnetic resonance perfusion imaging. Circulation. 2001;104(20):2412–6.

    CAS  PubMed  Google Scholar 

  53. Sourbron S. Technical aspects of MR perfusion. Eur J Radiol. 2010;76(3):304–13.

    PubMed  Google Scholar 

  54. Christian TF, Aletras AH, Arai AE. Estimation of absolute myocardial blood flow during first-pass MR perfusion imaging using a dual-bolus injection technique: comparison to single-bolus injection method. J Magn Reson Imaging. 2008;27(6):1271–7.

    PubMed  Google Scholar 

  55. Pack NA, DiBella EV, Rust TC, et al. Estimating myocardial perfusion from dynamic contrast-enhanced CMR with a model-independent deconvolution method. J Cardiovasc Magn Reson. 2008;10:52.

    PubMed Central  PubMed  Google Scholar 

  56. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med. 1987;316(23):1429–35.

    Google Scholar 

  57. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med. 1991;325(5):293–302.

    Google Scholar 

  58. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39(7):1151–8.

    PubMed  Google Scholar 

  59. Bax JJ, Poldermans D, Elhendy A, et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol. 1999;34(1):163–9.

    CAS  PubMed  Google Scholar 

  60. Gerber BL, Rousseau MF, Ahn SA, et al. Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy. J Am Coll Cardiol. 2012;59(9):825–35.

    PubMed  Google Scholar 

  61. Schinkel AF, Bax JJ, Poldermans D, et al. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol. 2007;32(7):375–410.

    PubMed  Google Scholar 

  62. Carluccio E, Biagioli P, Alunni G, et al. Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling. J Am Coll Cardiol. 2006;47(5):969–77.

    PubMed  Google Scholar 

  63. Rahimtoola SH, Dilsizian V, Kramer CM, Marwick TH, Vanoverschelde JL. Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice. JACC Cardiovasc Imaging. 2008;1(4):536–55.

    PubMed Central  PubMed  Google Scholar 

  64. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26(15):1461–74.

    PubMed  Google Scholar 

  65. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001;218(1):215–23.

    CAS  PubMed  Google Scholar 

  66. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100(19):1992–2002.

    CAS  PubMed  Google Scholar 

  67. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343(20):1445–53.

    CAS  PubMed  Google Scholar 

  68. Schvartzman PR, Srichai MB, Grimm RA, et al. Nonstress delayed-enhancement magnetic resonance imaging of the myocardium predicts improvement of function after revascularization for chronic ischemic heart disease with left ventricular dysfunction. Am Heart J. 2003;146(3):535–41.

    PubMed  Google Scholar 

  69. Selvanayagam JB, Kardos A, Francis JM, et al. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation. 2004;110(12):1535–41.

    PubMed  Google Scholar 

  70. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med. 2002;47(2):372–83.

    PubMed Central  PubMed  Google Scholar 

  71. Rizzello V, Schinkel AF, Bax JJ, et al. Individual prediction of functional recovery after coronary revascularization in patients with ischemic cardiomyopathy: the scar-to-biphasic model. Am J Cardiol. 2003;91(12):1406–9.

    PubMed  Google Scholar 

  72. Schinkel AF, Poldermans D, Rizzello V, et al. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization? J Thorac Cardiovasc Surg. 2004;127(2):385–90.

    PubMed  Google Scholar 

  73. Rahimtoola SH, La Canna G, Ferrari R. Hibernating myocardium: another piece of the puzzle falls into place. J Am Coll Cardiol. 2006;47(5):978–80.

    PubMed  Google Scholar 

  74. Glaveckaite S, Valeviciene N, Palionis D, et al. Value of scar imaging and inotropic reserve combination for the prediction of segmental and global left ventricular functional recovery after revascularisation. J Cardiovasc Magn Reson. 2011;13:35.

    PubMed Central  PubMed  Google Scholar 

  75. Wellnhofer E, Olariu A, Klein C, et al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation. 2004;109(18):2172–4.

    PubMed  Google Scholar 

  76. Jaffe R, Dick A, Strauss BH. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach. JACC Cardiovasc Interv. 2010;3(7):695–704.

    PubMed  Google Scholar 

  77. de Waha S, Desch S, Eitel I, et al. Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. Eur Heart J. 2010;31(21):2660–8.

    PubMed  Google Scholar 

  78. Mather AN, Lockie T, Nagel E, et al. Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction. J Cardiovasc Magn Reson. 2009;11:33.

    PubMed Central  PubMed  Google Scholar 

  79. Hombach V, Grebe O, Merkle N, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J. 2005;26(6):549–57.

    PubMed  Google Scholar 

  80. Cochet AA, Lorgis L, Lalande A, et al. Major prognostic impact of persistent microvascular obstruction as assessed by contrast-enhanced cardiac magnetic resonance in reperfused acute myocardial infarction. Eur Radiol. 2009;19(9):2117–26.

    PubMed  Google Scholar 

  81. Yan AT, Gibson CM, Larose E, et al. Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging. J Cardiovasc Magn Reson. 2006;8(6):831–7.

    PubMed  Google Scholar 

  82. Lund GK, Stork A, Saeed M, et al. Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl SPECT imaging. Radiology. 2004;232(1):49–57.

    PubMed  Google Scholar 

  83. Raff GL, O’Neill WW, Gentry RE, et al. Microvascular obstruction and myocardial function after acute myocardial infarction: assessment by using contrast-enhanced cine MR imaging. Radiology. 2006;240(2):529–36.

    PubMed  Google Scholar 

  84. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97(8):765–72.

    CAS  PubMed  Google Scholar 

  85. Kwong RY, Chan AK, Brown KA, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation. 2006;113(23):2733–43.

    PubMed  Google Scholar 

  86. Klem I, Shah DJ, White RD, et al. Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study. Circ Cardiovasc Imaging. 2011;4(6):610–9.

    PubMed  Google Scholar 

  87. Bello D, Fieno DS, Kim RJ, et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol. 2005;45(7):1104–8.

    PubMed  Google Scholar 

  88. de Bakker JM, van Capelle FJ, Janse MJ, et al. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation. 1988;77(3):589–606.

    PubMed  Google Scholar 

  89. Klem I, Weinsaft JW, Bahnson TD, et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol. 2012;60(5):408–20.

    PubMed Central  PubMed  Google Scholar 

  90. Scott PA, Morgan JM, Carroll N, et al. The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators. Circ Arrhythm Electrophysiol. 2011;4(3):324–30.

    PubMed  Google Scholar 

  91. Lowe JE, Reimer KA, Jennings RB. Experimental infarct size as a function of the amount of myocardium at risk. Am J Pathol. 1978;90(2):363–79.

    PubMed Central  CAS  PubMed  Google Scholar 

  92. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol. 2009;53(17):1475–87.

    PubMed Central  PubMed  Google Scholar 

  93. Eitel I, Desch S, Fuernau G, et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol. 2010;55(22):2470–9.

    PubMed  Google Scholar 

  94. Ugander M, Bagi PS, Oki AJ, et al. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging. 2012;5(6):596–603.

    PubMed Central  PubMed  Google Scholar 

  95. Abdel-Aty H, Cocker M, Meek C, Tyberg JV, Friedrich MG. Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study. J Am Coll Cardiol. 2009;53(14):1194–201.

    CAS  PubMed  Google Scholar 

  96. Friedrich MG, Abdel-Aty H, Taylor A, et al. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol. 2008;51(16):1581–7.

    PubMed  Google Scholar 

  97. Raman SV, Simonetti OP, Winner 3rd MW, et al. Cardiac magnetic resonance with edema imaging identifies myocardium at risk and predicts worse outcome in patients with non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol. 2010;55(22):2480–8.

    PubMed Central  PubMed  Google Scholar 

  98. Larose E, Rodes-Cabau J, Pibarot P, et al. Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance. J Am Coll Cardiol. 2010;55(22):2459–69.

    PubMed  Google Scholar 

  99. Eitel I, Desch S, de Waha S, et al. Long-term prognostic value of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. Heart. 2011;97(24):2038–45.

    PubMed  Google Scholar 

  100. Masci PG, Ganame J, Strata E, et al. Myocardial salvage by CMR correlates with LV remodeling and early ST-segment resolution in acute myocardial infarction. JACC Cardiovasc Imaging. 2010;3(1):45–51.

    PubMed  Google Scholar 

  101. Wince WB, Kim RJ. Molecular imaging: T2-weighted CMR of the area at risk—a risky business? Nature reviews. Cardiology. 2010;7(10):547–9.

    PubMed  Google Scholar 

  102. Aletras AH, Kellman P, Derbyshire JA, Arai AE. ACUT2E TSE-SSFP: a hybrid method for T2-weighted imaging of edema in the heart. Magn Reson Med. 2008;59(2):229–35.

    PubMed  Google Scholar 

  103. Kellman P, Aletras AH, Mancini C, McVeigh ER, Arai AE. T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo. Magn Reson Med. 2007;57(5):891–7.

    PubMed Central  PubMed  Google Scholar 

  104. Giri S, Chung YC, Merchant A, et al. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson. 2009;11:56.

    PubMed Central  PubMed  Google Scholar 

  105. Kellman P, Hernando D, Shah S, et al. Multiecho dixon fat and water separation method for detecting fibrofatty infiltration in the myocardium. Magn Reson Med. 2009;61(1):215–21.

    PubMed Central  CAS  PubMed  Google Scholar 

  106. Dixon WT. Simple proton spectroscopic imaging. Radiology. 1984;153(1):189–94.

    CAS  PubMed  Google Scholar 

  107. Bley TA, Wieben O, Francois CJ, Brittain JH, Reeder SB. Fat and water magnetic resonance imaging. J Magn Reson Imaging. 2010;31(1):4–18.

    PubMed  Google Scholar 

  108. Rossi MA. Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J Hypertens. 1998;16(7):1031–41.

    CAS  PubMed  Google Scholar 

  109. Conrad CH, Brooks WW, Hayes JA, et al. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation. 1995;91(1):161–70.

    CAS  PubMed  Google Scholar 

  110. Frank JS, Langer GA. The myocardial interstitium: its structure and its role in ionic exchange. J Cell Biol. 1974;60(3):586–601.

    PubMed Central  CAS  PubMed  Google Scholar 

  111. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005;111(2):186–93.

    PubMed  Google Scholar 

  112. White SK, Sado DM, Flett AS, Moon JC. Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging. Heart. 2012;98(10):773–9.

    PubMed  Google Scholar 

  113. Ugander M, Oki AJ, Hsu LY, et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J. 2012;33(10):1268–78.

    PubMed Central  CAS  PubMed  Google Scholar 

  114. Garcia-Dorado D, Andres-Villarreal M, Ruiz-Meana M, Inserte J, Barba I. Myocardial edema: a translational view. J Mol Cell Cardiol. 2012;52(5):931–9.

    CAS  PubMed  Google Scholar 

  115. Desai KV, Laine GA, Stewart RH, et al. Mechanics of the left ventricular myocardial interstitium: effects of acute and chronic myocardial edema. Am J Physiol Heart Circ Physiol. 2008;294(6):H2428–34.

    CAS  PubMed  Google Scholar 

  116. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22(23):2171–9.

    CAS  PubMed  Google Scholar 

  117. Anderson LJ. Assessment of iron overload with T2* magnetic resonance imaging. Prog Cardiovasc Dis. 2011;54(3):287–94.

    CAS  PubMed  Google Scholar 

  118. He T, Gatehouse PD, Smith GC, et al. Myocardial T2* measurements in iron-overloaded thalassemia: an in vivo study to investigate optimal methods of quantification. Magn Reson Med. 2008;60(5):1082–9.

    PubMed Central  PubMed  Google Scholar 

  119. He T, Gatehouse PD, Kirk P, et al. Black-blood T2* technique for myocardial iron measurement in thalassemia. J Magn Reson Imaging. 2007;25(6):1205–9.

    PubMed  Google Scholar 

  120. Carpenter JP, He T, Kirk P, et al. On T2* magnetic resonance and cardiac iron. Circulation. 2011;123(14):1519–28.

    PubMed Central  PubMed  Google Scholar 

  121. Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation. 2006;113(6):876–90.

    PubMed  Google Scholar 

  122. Fuster V, Gersh BJ, Giuliani ER, et al. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 1981;47(3):525–31.

    CAS  PubMed  Google Scholar 

  123. Calabrese F, Basso C, Carturan E, Valente M, Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: is there a role for viruses? Cardiovasc Pathol. 2006;15(1):11–7.

    PubMed  Google Scholar 

  124. Abdel-Aty H, Boye P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol. 2005;45(11):1815–22.

    PubMed  Google Scholar 

  125. Stensaeth KH, Hoffmann P, Fossum E, et al. Cardiac magnetic resonance visualizes acute and chronic myocardial injuries in myocarditis. Int J Cardiovasc Imaging. 2012;28(2):327–35.

    PubMed Central  PubMed  Google Scholar 

  126. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109(10):1250–8.

    PubMed  Google Scholar 

  127. Kellman P, Wilson JR, Xue H, et al. Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J Cardiovasc Magn Reson. 2012;14:64.

    PubMed Central  PubMed  Google Scholar 

  128. Mahrholdt H, Wagner A, Deluigi CC, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation. 2006;114(15):1581–90.

    PubMed  Google Scholar 

  129. Basso C, Corrado D, Marcus FI, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;373(9671):1289–300.

    PubMed  Google Scholar 

  130. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010;121(13):1533–41.

    PubMed Central  PubMed  Google Scholar 

  131. McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J. 1994;71(3):215–8.

    PubMed Central  CAS  PubMed  Google Scholar 

  132. Tansey DK, Aly Z, Sheppard MN. Fat in the right ventricle of the normal heart. Histopathology. 2005;46(1):98–104.

    CAS  PubMed  Google Scholar 

  133. Castillo E, Tandri H, Rodriguez ER, et al. Arrhythmogenic right ventricular dysplasia: ex vivo and in vivo fat detection with black-blood MR imaging. Radiology. 2004;232(1):38–48.

    PubMed  Google Scholar 

  134. Marcus FI, Fontaine GH, Guiraudon G, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982;65(2):384–98.

    CAS  PubMed  Google Scholar 

  135. Kayser HW, van der Wall EE, Sivananthan MU, et al. Diagnosis of arrhythmogenic right ventricular dysplasia: a review. Radiographics. 2002;22(3):639–48; discussion 649–50.

    PubMed  Google Scholar 

  136. Dalal D, Tandri H, Judge DP, et al. Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study. J Am Coll Cardiol. 2009;53(15):1289–99.

    PubMed  Google Scholar 

  137. Tandri H, Saranathan M, Rodriguez ER, et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol. 2005;45(1):98–103.

    PubMed  Google Scholar 

  138. Grosse-Wortmann L, Macgowan CK, Vidarsson L, Yoo SJ. Late gadolinium enhancement of the right ventricular myocardium: is it really different from the left ? J Cardiovasc Magn Reson. 2008;10:20.

    PubMed Central  PubMed  Google Scholar 

  139. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287(10):1308–20.

    PubMed  Google Scholar 

  140. Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;58(25):e212–60.

    CAS  PubMed  Google Scholar 

  141. Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005;112(6):855–61.

    PubMed  Google Scholar 

  142. Maron MS, Maron BJ, Harrigan C, et al. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol. 2009;54(3):220–8.

    PubMed  Google Scholar 

  143. Chun EJ, Choi SI, Jin KN, et al. Hypertrophic cardiomyopathy: assessment with MR imaging and multidetector CT. Radiographics. 2010;30(5):1309–28.

    PubMed  Google Scholar 

  144. Wilson JM, Villareal RP, Hariharan R, et al. Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy. Tex Heart Inst J. 2002;29(3):176–80.

    PubMed Central  PubMed  Google Scholar 

  145. Moon JC, McKenna WJ, McCrohon JA, et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003;41(9):1561–7.

    PubMed  Google Scholar 

  146. Teraoka K, Hirano M, Ookubo H, et al. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging. 2004;22(2):155–61.

    PubMed  Google Scholar 

  147. Kim RJ, Judd RM. Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death? J Am Coll Cardiol. 2003;41(9):1568–72.

    PubMed  Google Scholar 

  148. Choudhury L, Mahrholdt H, Wagner A, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40(12):2156–64.

    PubMed  Google Scholar 

  149. O’Hanlon R, Grasso A, Roughton M, et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010;56(11):867–74.

    PubMed  Google Scholar 

  150. Cannan CR, Reeder GS, Bailey KR, Melton 3rd LJ, Gersh BJ. Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990. Circulation. 1995;92(9):2488–95.

    CAS  PubMed  Google Scholar 

  151. Bruder O, Wagner A, Jensen CJ, et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010;56(11):875–87.

    PubMed  Google Scholar 

  152. Adabag AS, Maron BJ, Appelbaum E, et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol. 2008;51(14):1369–74.

    PubMed  Google Scholar 

  153. Rubinshtein R, Glockner JF, Ommen SR, et al. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail. 2010;3(1):51–8.

    PubMed  Google Scholar 

  154. Todiere G, Aquaro GD, Piaggi P, et al. Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2012;60(10):922–9.

    PubMed  Google Scholar 

  155. ten Cate FJ, Soliman OI, Michels M, et al. Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution. Circ Heart Fail. 2010;3(3):362–9.

    PubMed  Google Scholar 

  156. Sorajja P, Ommen SR, Holmes DR, et al. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2012;126(20):2374–80.

    PubMed  Google Scholar 

  157. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest. 1993;103(1):253–8.

    CAS  PubMed  Google Scholar 

  158. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58(6):1204–11.

    CAS  PubMed  Google Scholar 

  159. Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med. 1995;119(2):167–72.

    CAS  PubMed  Google Scholar 

  160. Gideon NM, Mannino DM. Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data. Am J Med. 1996;100(4):423–7.

    CAS  PubMed  Google Scholar 

  161. Roberts WC, McAllister Jr HA, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med. 1977;63(1):86–108.

    CAS  PubMed  Google Scholar 

  162. Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol. 2005;184(1):249–54.

    PubMed  Google Scholar 

  163. Cheong BY, Muthupillai R, Nemeth M, et al. The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2009;26(1):39–46.

    CAS  PubMed  Google Scholar 

  164. Ohira H, Tsujino I, Ishimaru S, et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging. 2008;35(5):933–41.

    PubMed  Google Scholar 

  165. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005;45(10):1683–90.

    PubMed  Google Scholar 

  166. Tadamura E, Yamamuro M, Kubo S, et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol. 2005;185(1):110–5.

    PubMed  Google Scholar 

  167. Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120(20):1969–77.

    PubMed Central  PubMed  Google Scholar 

  168. Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart. 2001;86(6):666–71.

    PubMed Central  CAS  PubMed  Google Scholar 

  169. Paterick TE, Umland MM, Jan MF, et al. Left ventricular noncompaction: a 25-year odyssey. J Am Soc Echocardiogr. 2012;25(4):363–75.

    PubMed  Google Scholar 

  170. Freedom RM, Yoo SJ, Perrin D, et al. The morphological spectrum of ventricular noncompaction. Cardiol Young. 2005;15(4):345–64.

    PubMed  Google Scholar 

  171. Sedmera D, Pexieder T, Vuillemin M, Thompson RP, Anderson RH. Developmental patterning of the myocardium. Anat Rec. 2000;258(4):319–37.

    CAS  PubMed  Google Scholar 

  172. Stollberger C, Finsterer J. Left ventricular hypertrabeculation/noncompaction. J Am Soc Echocardiogr. 2004;17(1):91–100.

    PubMed  Google Scholar 

  173. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113(14):1807–16.

    PubMed  Google Scholar 

  174. Stahli BE, Gebhard C, Biaggi P, et al. Left ventricular non-compaction: prevalence in congenital heart disease. Int J Cardiol. 2013;167:2477–81.

    PubMed  Google Scholar 

  175. Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2005;46(1):101–5.

    PubMed  Google Scholar 

  176. Jacquier A, Thuny F, Jop B, et al. Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. Eur Heart J. 2010;31(9):1098–104.

    PubMed  Google Scholar 

  177. Grothoff M, Pachowsky M, Hoffmann J, et al. Value of cardiovascular MR in diagnosing left ventricular non-compaction cardiomyopathy and in discriminating between other cardiomyopathies. Eur Radiol. 2012;22(12):2699–709.

    PubMed Central  PubMed  Google Scholar 

  178. Chin TK, Perloff JK, Williams RG, Jue K, Mohrmann R. Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation. 1990;82(2):507–13.

    CAS  PubMed  Google Scholar 

  179. Frischknecht BS, Attenhofer Jost CH, Oechslin EN, et al. Validation of noncompaction criteria in dilated cardiomyopathy, and valvular and hypertensive heart disease. J Am Soc Echocardiogr. 2005;18(8):865–72.

    PubMed  Google Scholar 

  180. Stollberger C, Finsterer J, Blazek G. Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol. 2002;90(8):899–902.

    PubMed  Google Scholar 

  181. Oechslin EN, Attenhofer Jost CH, Rojas JR, Kaufmann PA, Jenni R. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol. 2000;36(2):493–500.

    CAS  PubMed  Google Scholar 

  182. Alhabshan F, Smallhorn JF, Golding F, et al. Extent of myocardial non-compaction: comparison between MRI and echocardiographic evaluation. Pediatr Radiol. 2005;35(11):1147–51.

    PubMed  Google Scholar 

  183. Dawson DK, Maceira AM, Raj VJ, et al. Regional thicknesses and thickening of compacted and trabeculated myocardial layers of the normal left ventricle studied by cardiovascular magnetic resonance. Circ Cardiovasc Imaging. 2011;4(2):139–46.

    PubMed Central  PubMed  Google Scholar 

  184. Pujadas S, Bordes R, Bayes-Genis A. Ventricular non-compaction cardiomyopathy: CMR and pathology findings. Heart. 2005;91(5):582.

    PubMed Central  CAS  PubMed  Google Scholar 

  185. Alsaileek AA, Syed I, Seward JB, Julsrud P. Myocardial fibrosis of left ventricle: magnetic resonance imaging in noncompaction. J Magn Reson Imaging. 2008;27(3):621–4.

    PubMed  Google Scholar 

  186. Ivan D, Flamm SD, Abrams J, et al. Isolated ventricular non-compaction in adults with idiopathic cardiomyopathy: cardiac magnetic resonance and pathologic characterization of the anomaly. J Heart Lung Transplant. 2005;24(6):781–6.

    PubMed  Google Scholar 

  187. Dodd JD, Holmvang G, Hoffmann U, et al. Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI: correlation with clinical severity. AJR Am J Roentgenol. 2007;189(4):974–80.

    PubMed  Google Scholar 

  188. Dursun M, Agayev A, Nisli K, et al. MR imaging features of ventricular noncompaction: emphasis on distribution and pattern of fibrosis. Eur J Radiol. 2010;74(1):147–51.

    PubMed  Google Scholar 

  189. Nucifora G, Aquaro GD, Pingitore A, Masci PG, Lombardi M. Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity. Eur J Heart Fail. 2011;13(2):170–6.

    PubMed  Google Scholar 

  190. Chaowu Y, Li L, Shihua Z. Histopathological features of delayed enhancement cardiovascular magnetic resonance in isolated left ventricular noncompaction. J Am Coll Cardiol. 2011;58(3):311–2.

    PubMed  Google Scholar 

  191. Jenni R, Wyss CA, Oechslin EN, Kaufmann PA. Isolated ventricular noncompaction is associated with coronary microcirculatory dysfunction. J Am Coll Cardiol. 2002;39(3):450–4.

    PubMed  Google Scholar 

  192. Junga G, Kneifel S, Von Smekal A, Steinert H, Bauersfeld U. Myocardial ischaemia in children with isolated ventricular non-compaction. Eur Heart J. 1999;20(12):910–6.

    CAS  PubMed  Google Scholar 

  193. Kohli SK, Pantazis AA, Shah JS, et al. Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J. 2008;29(1):89–95.

    PubMed  Google Scholar 

  194. Kawel N, Nacif M, Arai AE, et al. Trabeculated (noncompacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging. 2012;5(3):357–66.

    PubMed Central  PubMed  Google Scholar 

  195. Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005;112(13):2047–60.

    PubMed  Google Scholar 

  196. Rahman JE, Helou EF, Gelzer-Bell R, et al. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol. 2004;43(3):410–5.

    PubMed  Google Scholar 

  197. Fattori R, Rocchi G, Celletti F, et al. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy. Am Heart J. 1998;136(5):824–30.

    CAS  PubMed  Google Scholar 

  198. Syed IS, Glockner JF, Feng D, et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging. 2010;3(2):155–64.

    PubMed  Google Scholar 

  199. Vogelsberg H, Mahrholdt H, Deluigi CC, et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol. 2008;51(10):1022–30.

    PubMed  Google Scholar 

  200. Krombach GA, Hahn C, Tomars M, et al. Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects. J Magn Reson Imaging. 2007;25(6):1283–7.

    PubMed  Google Scholar 

  201. Van den Driesen RI, Slaughter RE, Strugnell WE. MR findings in cardiac amyloidosis. AJR Am J Roentgenol. 2006;186(6):1682–5.

    Google Scholar 

  202. Kieninger B, Eriksson M, Kandolf R, et al. Amyloid in endomyocardial biopsies. Virchows Arch. 2010;456(5):523–32.

    CAS  PubMed  Google Scholar 

  203. Austin BA, Tang WH, Rodriguez ER, et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging. 2009;2(12):1369–77.

    PubMed  Google Scholar 

  204. Mongeon FP, Jerosch-Herold M, Coelho-Filho OR, et al. Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. JACC Cardiovasc Imaging. 2012;5(9):897–907.

    PubMed Central  PubMed  Google Scholar 

  205. Hosch W, Bock M, Libicher M, et al. MR-relaxometry of myocardial tissue: significant elevation of T1 and T2 relaxation times in cardiac amyloidosis. Invest Radiol. 2007;42(9):636–42.

    PubMed  Google Scholar 

  206. Ruberg FL, Appelbaum E, Davidoff R, et al. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol. 2009;103(4):544–9.

    PubMed Central  PubMed  Google Scholar 

  207. Migrino RQ, Christenson R, Szabo A, et al. Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up. BMC Med Phys. 2009;9:5.

    PubMed Central  PubMed  Google Scholar 

  208. Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson. 2008;10:54.

    PubMed Central  PubMed  Google Scholar 

  209. Hurst RT, Prasad A, Askew 3rd JW, Sengupta PP, Tajik AJ. Takotsubo cardiomyopathy: a unique cardiomyopathy with variable ventricular morphology. JACC Cardiovasc Imaging. 2010;3(6):641–9.

    PubMed  Google Scholar 

  210. Koulouris S, Pastromas S, Sakellariou D, et al. Takotsubo cardiomyopathy: the “broken heart” syndrome. Hellenic J Cardiol. 2010;51(5):451–7.

    PubMed  Google Scholar 

  211. Milinis K, Fisher M. Takotsubo cardiomyopathy: pathophysiology and treatment. Postgrad Med J. 2012;88(1043):530–8.

    PubMed  Google Scholar 

  212. Kawai S, Suzuki H, Yamaguchi H, et al. Ampulla cardiomyopathy (‘Takotusbo’ cardiomyopathy)—reversible left ventricular dysfunction: with ST segment elevation. Jpn Circ J. 2000;64(2):156–9.

    CAS  PubMed  Google Scholar 

  213. Singh NK, Rumman S, Mikell FL, Nallamothu N, Rangaswamy C. Stress cardiomyopathy: clinical and ventriculographic characteristics in 107 North American subjects. Int J Cardiol. 2010;141(3):297–303.

    PubMed  Google Scholar 

  214. Haghi D, Athanasiadis A, Papavassiliu T, et al. Right ventricular involvement in Takotsubo cardiomyopathy. Eur Heart J. 2006;27(20):2433–9.

    PubMed  Google Scholar 

  215. Korlakunta H, Butkevich A, Muthupillai R, Cheong BY. Biventricular takotsubo cardiomyopathy: cardiac magnetic resonance imaging as useful diagnostic tool. Tex Heart Inst J. 2011;38(1):88–9.

    PubMed Central  PubMed  Google Scholar 

  216. Elesber AA, Prasad A, Bybee KA, et al. Transient cardiac apical ballooning syndrome: prevalence and clinical implications of right ventricular involvement. J Am Coll Cardiol. 2006;47(5):1082–3.

    PubMed  Google Scholar 

  217. Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P, et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA. 2011;306(3):277–86.

    CAS  PubMed  Google Scholar 

  218. Fernandez-Perez GC, Aguilar-Arjona JA, de la Fuente GT, et al. Takotsubo cardiomyopathy: assessment with cardiac MRI. AJR Am J Roentgenol. 2010;195(2):W139–45.

    PubMed  Google Scholar 

  219. Otsuka Y, Noguchi T, Goto Y, Nonogi H, Yamada N. Hyperintensity on T2-weighted magnetic resonance imaging in Takotsubo cardiomyopathy. Int J Cardiol. 2008;130(1):113–6.

    PubMed  Google Scholar 

  220. Neil C, Nguyen TH, Kucia A, et al. Slowly resolving global myocardial inflammation/oedema in Tako-Tsubo cardiomyopathy: evidence from T2-weighted cardiac MRI. Heart. 2012;98(17):1278–84.

    PubMed  Google Scholar 

  221. Abdel-Aty H, Cocker M, Friedrich MG. Myocardial edema is a feature of Tako-Tsubo cardiomyopathy and is related to the severity of systolic dysfunction: insights from T2-weighted cardiovascular magnetic resonance. Int J Cardiol. 2009;132(2):291–3.

    PubMed  Google Scholar 

  222. Rolf A, Nef HM, Mollmann H, et al. Immunohistological basis of the late gadolinium enhancement phenomenon in tako-tsubo cardiomyopathy. Eur Heart J. 2009;30(13):1635–42.

    PubMed  Google Scholar 

  223. Sharkey SW, Lesser JR, Zenovich AG, et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation. 2005;111(4):472–9.

    PubMed  Google Scholar 

  224. Mitchell JH, Hadden TB, Wilson JM, et al. Clinical features and usefulness of cardiac magnetic resonance imaging in assessing myocardial viability and prognosis in Takotsubo cardiomyopathy (transient left ventricular apical ballooning syndrome). Am J Cardiol. 2007;100(2):296–301.

    PubMed  Google Scholar 

  225. Nef HM, Mollmann H, Kostin S, et al. Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J. 2007;28(20):2456–64.

    PubMed  Google Scholar 

  226. Rassi Jr A, Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation. 2007;115(9):1101–8.

    PubMed  Google Scholar 

  227. Biolo A, Ribeiro AL, Clausell N. Chagas cardiomyopathy—where do we stand after a hundred years? Prog Cardiovasc Dis. 2010;52(4):300–16.

    CAS  PubMed  Google Scholar 

  228. Nunes MC, Barbosa MM, Ribeiro AL, Colosimo EA, Rocha MO. Left atrial volume provides independent prognostic value in patients with Chagas cardiomyopathy. J Am Soc Echocardiogr. 2009;22(1):82–8.

    PubMed  Google Scholar 

  229. Rassi Jr A, Rassi A, Little WC, et al. Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med. 2006;355(8):799–808.

    CAS  PubMed  Google Scholar 

  230. Regueiro A, Garcia-Alvarez A, Sitges M, et al. Myocardial involvement in Chagas disease: insights from cardiac magnetic resonance. Int J Cardiol. 2013;165:107–12.

    PubMed  Google Scholar 

  231. Rochitte CE, Oliveira PF, Andrade JM, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: a marker of disease severity. J Am Coll Cardiol. 2005;46(8):1553–8.

    PubMed  Google Scholar 

  232. de Mello RP, Szarf G, Schvartzman PR, et al. Delayed enhancement cardiac magnetic resonance imaging can identify the risk for ventricular tachycardia in chronic Chagas’ heart disease. Arq Bras Cardiol. 2012;98(5):421–30.

    PubMed  Google Scholar 

  233. Rochitte CE, Nacif MS, de Oliveira Junior AC, et al. Cardiac magnetic resonance in Chagas’ disease. Artif Organs. 2007;31(4):259–67.

    PubMed  Google Scholar 

  234. Hoffmann B. Fabry disease: recent advances in pathology, diagnosis, treatment and monitoring. Orphanet J Rare Dis. 2009;4:21.

    PubMed Central  PubMed  Google Scholar 

  235. Nagueh SF. Fabry disease. Heart. 2003;89(8):819–20.

    PubMed Central  CAS  PubMed  Google Scholar 

  236. De Cobelli F, Esposito A, Belloni E, et al. Delayed-enhanced cardiac MRI for differentiation of Fabry’s disease from symmetric hypertrophic cardiomyopathy. AJR Am J Roentgenol. 2009;192(3):W97–102.

    PubMed  Google Scholar 

  237. Moon JC, Sachdev B, Elkington AG, et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J. 2003;24(23):2151–5.

    PubMed  Google Scholar 

  238. Imbriaco M, Spinelli L, Cuocolo A, et al. MRI characterization of myocardial tissue in patients with Fabry’s disease. AJR Am J Roentgenol. 2007;188(3):850–3.

    PubMed  Google Scholar 

  239. Imbriaco M, Pisani A, Spinelli L, et al. Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study. Heart. 2009;95(13):1103–7.

    CAS  PubMed  Google Scholar 

  240. Messalli G, Imbriaco M, Avitabile G, et al. Role of cardiac MRI in evaluating patients with Anderson-Fabry disease: assessing cardiac effects of long-term enzyme replacement therapy. Radiol Med. 2012;117(1):19–28.

    CAS  PubMed  Google Scholar 

  241. Liu P, Olivieri N. Iron overload cardiomyopathies: new insights into an old disease. Cardiovasc Drugs Ther. 1994;8(1):101–10.

    CAS  PubMed  Google Scholar 

  242. Qaseem A, Aronson M, Fitterman N, et al. Screening for hereditary hemochromatosis: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2005;143(7):517–21.

    CAS  PubMed  Google Scholar 

  243. Tanner MA, Galanello R, Dessi C, et al. Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. J Cardiovasc Magn Reson. 2008;10:12.

    PubMed Central  PubMed  Google Scholar 

  244. Wood JC. History and current impact of cardiac magnetic resonance imaging on the management of iron overload. Circulation. 2009;120(20):1937–9.

    PubMed Central  PubMed  Google Scholar 

  245. Kremastinos DT, Farmakis D. Iron overload cardiomyopathy in clinical practice. Circulation. 2011;124(20):2253–63.

    PubMed  Google Scholar 

  246. Gujja P, Rosing DR, Tripodi DJ, Shizukuda Y. Iron overload cardiomyopathy: better understanding of an increasing disorder. J Am Coll Cardiol. 2010;56(13):1001–12.

    PubMed Central  CAS  PubMed  Google Scholar 

  247. Modell B, Khan M, Darlison M, et al. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10:42.

    PubMed Central  PubMed  Google Scholar 

  248. Wood JC, Otto-Duessel M, Aguilar M, et al. Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation. 2005;112(4):535–43.

    PubMed Central  CAS  PubMed  Google Scholar 

  249. Kirk P, Roughton M, Porter JB, et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation. 2009;120(20):1961–8.

    PubMed Central  CAS  PubMed  Google Scholar 

  250. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2–220.

    PubMed  Google Scholar 

  251. Bashore TM, Balter S, Barac A, et al. 2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update. A report of the American College of Cardiology Foundation Task Force on Expert Consensus documents. J Am Coll Cardiol. 2012;59(24):2221–305.

    PubMed  Google Scholar 

  252. Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362(10):886–95.

    PubMed Central  CAS  PubMed  Google Scholar 

  253. Mowatt G, Cook JA, Hillis GS, et al. 64-Slice computed tomography angiography in the diagnosis and assessment of coronary artery disease: systematic review and meta-analysis. Heart. 2008;94(11):1386–93.

    CAS  PubMed  Google Scholar 

  254. Paulin S, von Schulthess GK, Fossel E, Krayenbuehl HP. MR imaging of the aortic root and proximal coronary arteries. AJR Am J Roentgenol. 1987;148(4):665–70.

    CAS  PubMed  Google Scholar 

  255. Wielopolski PA, Manning WJ, Edelman RR. Single breath-hold volumetric imaging of the heart using magnetization-prepared 3-dimensional segmented echo planar imaging. J Magn Reson Imaging. 1995;5(4):403–9.

    CAS  PubMed  Google Scholar 

  256. Bashore TM, Bates ER, Berger PB, et al. American College of Cardiology/Society for Cardiac Angiography and Interventions clinical expert consensus document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001;37(8):2170–214.

    CAS  PubMed  Google Scholar 

  257. Flamm SD, Muthupillai R. Coronary artery magnetic resonance angiography. J Magn Reson Imaging. 2004;19(6):686–709.

    PubMed  Google Scholar 

  258. Huber ME, Kozerke S, Pruessmann KP, Smink J, Boesiger P. Sensitivity-encoded coronary MRA at 3T. Magn Reson Med. 2004;52(2):221–7.

    PubMed  Google Scholar 

  259. Nagata M, Kato S, Kitagawa K, et al. Diagnostic accuracy of 1.5-T unenhanced whole-heart coronary MR angiography performed with 32-channel cardiac coils: initial single-center experience. Radiology. 2011;259(2):384–92.

    PubMed  Google Scholar 

  260. Yang Q, Li K, Liu X, et al. 3.0T whole-heart coronary magnetic resonance angiography performed with 32-channel cardiac coils: a single-center experience. Circ Cardiovasc Imaging. 2012;5(5):573–9.

    PubMed Central  PubMed  Google Scholar 

  261. Wang Y, Vidan E, Bergman GW. Cardiac motion of coronary arteries: variability in the rest period and implications for coronary MR angiography. Radiology. 1999;213(3):751–8.

    CAS  PubMed  Google Scholar 

  262. Wielopolski PA, van Geuns RJ, de Feyter PJ, Oudkerk M. Breath-hold coronary MR angiography with volume-targeted imaging. Radiology. 1998;209(1):209–19.

    CAS  PubMed  Google Scholar 

  263. Ehman RL, Felmlee JP. Adaptive technique for high-definition MR imaging of moving structures. Radiology. 1989;173(1):255–63.

    CAS  PubMed  Google Scholar 

  264. Wang Y, Riederer SJ, Ehman RL. Respiratory motion of the heart: kinematics and the implications for the spatial resolution in coronary imaging. Magn Reson Med. 1995;33(5):713–9.

    CAS  PubMed  Google Scholar 

  265. Kato S, Kitagawa K, Ishida N, et al. Assessment of coronary artery disease using magnetic resonance coronary angiography: a national multicenter trial. J Am Coll Cardiol. 2010;56(12):983–91.

    PubMed  Google Scholar 

  266. Weber OM, Martin AJ, Higgins CB. Whole-heart steady-state free precession coronary artery magnetic resonance angiography. Magn Reson Med. 2003;50(6):1223–8.

    PubMed  Google Scholar 

  267. Sakuma H, Ichikawa Y, Chino S, et al. Detection of coronary artery stenosis with whole-heart coronary magnetic resonance angiography. J Am Coll Cardiol. 2006;48(10):1946–50.

    PubMed  Google Scholar 

  268. Yang Q, Li K, Liu X, et al. Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0-T: a comparative study with X-ray angiography in a single center. J Am Coll Cardiol. 2009;54(1):69–76.

    PubMed Central  PubMed  Google Scholar 

  269. Wieben O, Francois C, Reeder SB. Cardiac MRI of ischemic heart disease at 3T: potential and challenges. Eur J Radiol. 2008;65(1):15–28.

    PubMed  Google Scholar 

  270. Brittain JH, Hu BS, Wright GA, et al. Coronary angiography with magnetization-prepared T2 contrast. Magn Reson Med. 1995;33(5):689–96.

    CAS  PubMed  Google Scholar 

  271. Kim WY, Danias PG, Stuber M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med. 2001;345(26):1863–9.

    CAS  PubMed  Google Scholar 

  272. Nagel E. Magnetic resonance coronary angiography: the condemned live longer. J Am Coll Cardiol. 2010;56(12):992–4.

    PubMed  Google Scholar 

  273. Arbab-Zadeh A, Miller JM, Rochitte CE, et al. Diagnostic accuracy of computed tomography coronary angiography according to pre-test probability of coronary artery disease and severity of coronary arterial calcification. The CORE-64 (Coronary Artery Evaluation Using 64-Row Multidetector Computed Tomography Angiography) International Multicenter Study. J Am Coll Cardiol. 2012;59(4):379–87.

    PubMed Central  PubMed  Google Scholar 

  274. Miller JM, Rochitte CE, Dewey M, et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med. 2008;359(22):2324–36.

    CAS  PubMed  Google Scholar 

  275. Taylor AJ, Cerqueira M, Hodgson JM, et al. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2010;56(22):1864–94.

    PubMed  Google Scholar 

  276. Liu X, Zhao X, Huang J, et al. Comparison of 3D free-breathing coronary MR angiography and 64-MDCT angiography for detection of coronary stenosis in patients with high calcium scores. AJR Am J Roentgenol. 2007;189(6):1326–32.

    PubMed Central  PubMed  Google Scholar 

  277. Bluemke DA, Achenbach S, Budoff M, et al. Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention, and the Councils on Clinical Cardiology and Cardiovascular Disease in the Young. Circulation. 2008;118(5):586–606.

    PubMed  Google Scholar 

  278. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young. Pediatrics. 2004;114(6):1708–33.

    PubMed  Google Scholar 

  279. Shulman ST, Rowley AH. Advances in Kawasaki disease. Eur J Pediatr. 2004;163(6):285–91.

    PubMed  Google Scholar 

  280. Greil GF, Stuber M, Botnar RM, et al. Coronary magnetic resonance angiography in adolescents and young adults with kawasaki disease. Circulation. 2002;105(8):908–11.

    PubMed  Google Scholar 

  281. Angelini P, Monge J. Newer concepts regarding adults with coronary artery aneurysms: are they all Kawasaki? Does it make a difference? Circulation. 2012;125(25):3076–8.

    PubMed  Google Scholar 

  282. Yamanaka O, Hobbs RE. Coronary artery anomalies in 126,595 patients undergoing coronary arteriography. Cathet Cardiovasc Diagn. 1990;21(1):28–40.

    CAS  PubMed  Google Scholar 

  283. Angelini P, Shah NR, Uribe CE, et al. Novel MRI-based screening protocol to identify adolescents at high risk of sudden cardiac death (abstract). J Am Coll Cardiol. 2013;61(10S):E1621.

    Google Scholar 

  284. Machado C, Bhasin S, Soulen RL. Confirmation of anomalous origin of the right coronary artery from the left sinus of Valsalva with magnetic resonance imaging. Chest. 1993;104(4):1284–6.

    CAS  PubMed  Google Scholar 

  285. McConnell MV, Ganz P, Selwyn AP, et al. Identification of anomalous coronary arteries and their anatomic course by magnetic resonance coronary angiography. Circulation. 1995;92(11):3158–62.

    CAS  PubMed  Google Scholar 

  286. Post JC, van Rossum AC, Bronzwaer JG, et al. Magnetic resonance angiography of anomalous coronary arteries. A new gold standard for delineating the proximal course? Circulation. 1995;92(11):3163–71.

    CAS  PubMed  Google Scholar 

  287. Angelini P. Coronary artery anomalies: an entity in search of an identity. Circulation. 2007;115(10):1296–305.

    PubMed  Google Scholar 

  288. Angelini P, Villason S, Chan AV, Diez JG. Normal and anomalous coronary arteries in humans. In: Angelini P, editor. Coronary artery anomalies. Philadelphia: Lippincott Williams & Wilkins; 1999. p. 27–150.

    Google Scholar 

  289. Angelini P, Flamm SD. Newer concepts for imaging anomalous aortic origin of the coronary arteries in adults. Catheter Cardiovasc Interv. 2007;69(7):942–54.

    PubMed  Google Scholar 

  290. Angelini P, Monge J. Coronary artery anomalies. In: Morsucci M, editor. Grossman’s cardiac catheterization, angiography, and intervention. 8th ed. Riverwoods: Lippincott Williams & Wilkins; 2013.

    Google Scholar 

  291. Angelini P, Monge JU, Forstall P, et al. Anomalous right coronary artery from the left sinus of Valsalva: pathophysiological mechanisms studied by intravascular ultrasound, clinical presentations and response to stent angioplasty (abstract). J Am Coll Cardiol. 2013;61:E18.

    Google Scholar 

  292. Angelini P, Cheong B. Left coronary artery from the right coronary sinus: what can CT angiography tell us? J Cardiovasc Comput Tomogr. 2010;4(4):255–7.

    PubMed  Google Scholar 

  293. Mohlenkamp S, Hort W, Ge J, Erbel R. Update on myocardial bridging. Circulation. 2002;106(20):2616–22.

    PubMed  Google Scholar 

  294. Prati F, Regar E, Mintz GS, et al. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J. 2010;31(4):401–15.

    PubMed  Google Scholar 

  295. Tearney GJ, Regar E, Akasaka T, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol. 2012;59(12):1058–72.

    PubMed  Google Scholar 

  296. Cowles RA, Berdon WE. Bland-White-Garland syndrome of anomalous left coronary artery arising from the pulmonary artery (ALCAPA): a historical review. Pediatr Radiol. 2007;37(9):890–5.

    PubMed  Google Scholar 

  297. Douard H, Barat JL, Laurent F, et al. Magnetic resonance imaging of an anomalous origin of the left coronary artery from the pulmonary artery. Eur Heart J. 1988;9(12):1356–60.

    CAS  PubMed  Google Scholar 

  298. Komocsi A, Simor T, Toth L, et al. Magnetic resonance studies in management of adult cases with Bland-White-Garland syndrome. Int J Cardiol. 2007;123(1):e8–11.

    PubMed  Google Scholar 

  299. Molinari G, Balbi M, Bertero G, et al. Magnetic resonance imaging in Bland-White-Garland syndrome. Am Heart J. 1995;129(5):1040–2.

    CAS  PubMed  Google Scholar 

  300. Pena E, Nguyen ET, Merchant N, Dennie G. ALCAPA syndrome: not just a pediatric disease. Radiographics. 2009;29(2):553–65.

    PubMed  Google Scholar 

  301. Yau JM, Singh R, Halpern EJ, Fischman D. Anomalous origin of the left coronary artery from the pulmonary artery in adults: a comprehensive review of 151 adult cases and a new diagnosis in a 53-year-old woman. Clin Cardiol. 2011;34(4):204–10.

    PubMed  Google Scholar 

  302. Lee DC, Johnson NP. Quantification of absolute myocardial blood flow by magnetic resonance perfusion imaging. JACC Cardiovasc Imaging. 2009;2:761–70.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Advanced Cardiovascular Imaging (MR/CT), Department of Radiology, St. Luke’s Hospital/Texas Heart Institute, Houston, TX, USA

    Benjamin Y. C. Cheong MD, FRCP(Edin)

  2. Departments of Medicine, Cardiology, and Radiology, Baylor College of Medicine, Houston, TX, USA

    Benjamin Y. C. Cheong MD, FRCP(Edin)

  3. Department of Medicine, Baylor College of Medicine, Houston, TX, USA

    Paolo Angelini MD, FSCAI

  4. Department of Cardiology, St. Luke’s Hospital, Houston, TX, USA

    Paolo Angelini MD, FSCAI

  5. Center for Coronary Artery Anomalies, Texas Heart Institute, Houston, TX, USA

    Paolo Angelini MD, FSCAI

Authors
  1. Benjamin Y. C. Cheong MD, FRCP(Edin)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paolo Angelini MD, FSCAI
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Benjamin Y. C. Cheong MD, FRCP(Edin) .

Editor information

Editors and Affiliations

  1. Cardiology Division, President, Texas Heart Institute, Houston, Texas, USA

    James T. Willerson

  2. Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota, USA

    David R. Holmes, Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Cheong, B.Y.C., Angelini, P. (2015). Magnetic Resonance Imaging of the Myocardium, Coronary Arteries, and Anomalous Origin of Coronary Arteries. In: Willerson, J., Holmes, Jr., D. (eds) Coronary Artery Disease. Cardiovascular Medicine. Springer, London. https://doi.org/10.1007/978-1-4471-2828-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2828-1_13

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2827-4

  • Online ISBN: 978-1-4471-2828-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation